Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5)

by Nauck, Michael, Weinstock, Ruth S., Umpierrez, Guillermo E., Guerci, Bruno, Skrivanek, Zachary, Milicevic, Zvonko
Published 2014

Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks

by Diamant, Michaela, Van Gaal, Luc, Stranks, Stephen, Guerci, Bruno, MacConell, Leigh, Haber, Harry, Scism-Bacon, Jamie, Trautmann, Michael
Published 2012

Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study

by Simó, Rafael, Guerci, Bruno, Schernthaner, Guntram, Gallwitz, Baptist, Rosas-Guzmàn, Juan, Dotta, Francesco, Festa, Andreas, Zhou, Ming, Kiljański, Jacek
Published 2015

Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries

by Östenson, Claes-Göran, Matthaei, Stephan, Reaney, Matthew, Krarup, Thure, Guerci, Bruno, Kiljanski, Jacek, Salaun-Martin, Carole, Sapin, Hélène, Bruhn, David, Mathieu, Chantal, Theodorakis, Michael
Published 2013

Patients with Type 2 Diabetes Initiating Exenatide Twice Daily or Insulin in Clinical Practice: CHOICE Study

by Matthaei, Stephan, Reaney, Matthew, Mathieu, Chantal, Östenson, Claes-Göran, Krarup, Thure, Guerci, Bruno, Kiljanski, Jacek, Petto, Helmut, Bruhn, David, Theodorakis, Michael
Published 2012

Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study

by Reaney, Matthew, Mathieu, Chantal, Östenson, Claes-Göran, Matthaei, Stephan, Krarup, Thure, Kiljański, Jacek, Salaun-Martin, Carole, Sapin, Hélène, Theodorakis, Michael, Guerci, Bruno
Published 2013

Using Exenatide Twice Daily or Insulin in Clinical Practice: Results from CHOICE

by Mathieu, Chantal, Östenson, Claes-Göran, Matthaei, Stephan, Reaney, Matthew, Krarup, Thure, Guerci, Bruno, Kiljański, Jacek, Salaun-Martin, Carole, Sapin, Hélène, Theodorakis, Michael
Published 2013

Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study

by Kiiskinen, Urpo, Matthaei, Stephan, Reaney, Matthew, Mathieu, Chantal, Östenson, Claes-Göran, Krarup, Thure, Theodorakis, Michael, Kiljański, Jacek, Salaun-Martin, Carole, Sapin, Hélène, Guerci, Bruno
Published 2013

The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study

by Conget, Ignacio, Castaneda, Javier, Petrovski, Goran, Guerci, Bruno, Racault, Anne-Sophie, Reznik, Yves, Cohen, Ohad, Runzis, Sarah, de Portu, Simona, Aronson, Ronnie
Published 2016

Assessment of Patient-Led or Physician-Driven Continuous Glucose Monitoring in Patients With Poorly Controlled Type 1 Diabetes Using Basal-Bolus Insulin Regimens: A 1-year multicen...

by Riveline, Jean-Pierre, Schaepelynck, Pauline, Chaillous, Lucy, Renard, Eric, Sola-Gazagnes, Agnès, Penfornis, Alfred, Tubiana-Rufi, Nadia, Sulmont, Véronique, Catargi, Bogdan, Lukas, Céline, Radermecker, Régis P., Thivolet, Charles, Moreau, François, Benhamou, Pierre-Yves, Guerci, Bruno, Leguerrier, Anne-Marie, Millot, Luc, Sachon, Claude, Charpentier, Guillaume, Hanaire, Hélène
Published 2012